The analysis showed that ZFX expression was significantly higher in CD34+ cells than in unfractioned BMCs (Additional file 1: Fig. S1A), which suggested that ZFX may play a crucial role in both normal and CML stem/progenitor cells. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.